23 Jul

Genentech’s troubles highlight biosimilar trade secret risks

While Genentech has been extremely effective in the enforcement of its trade secret rights, the story of Taiwanese biotech, JHL, shows why strategies for protecting proprietary know-how are essential in the biologics space

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth